Show simple item record

dc.contributor.authorPikora, Cheryl A.
dc.contributor.authorSullivan, John L.
dc.contributor.authorPanicali, Dennis
dc.contributor.authorLuzuriaga, Katherine
dc.date2022-08-11T08:09:02.000
dc.date.accessioned2022-08-23T16:16:28Z
dc.date.available2022-08-23T16:16:28Z
dc.date.issued1997-04-07
dc.date.submitted2008-11-25
dc.identifier.citation<p>J Exp Med. 1997 Apr 7;185(7):1153-61.</p>
dc.identifier.issn0022-1007 (Print)
dc.identifier.doi10.1084/jem.185.7.1153
dc.identifier.pmid9104802
dc.identifier.urihttp://hdl.handle.net/20.500.14038/34340
dc.description.abstractHigh frequencies of cytotoxic T lymphocyte precursors (CTLp) recognizing HIV-1 laboratory strain gene products have been detected in adults within weeks of primary infection. In contrast, HIV-1-specific CTLp are uncommonly detected in infants younger than 6 mo. To address the hypothesis that the use of target cells expressing laboratory strain env gene products might limit the detection of HIV-1 env-specific CTLp in early infancy, recombinant vaccinia vectors (vv) expressing HIV-1 env genes from early isolates of four vertically infected infants were generated. The frequencies of CTLp recognizing target cells infected with vv-expressing env gene products from early isolates and HIV-1 IIIB were serially measured using limiting dilution followed by in vitro stimulation with mAb to CD3. In one infant, the detection of early isolate env-specific CTLp preceded the detection of IIIB-specific CTLp. CTLp recognizing HIV-1 IIIB and infant isolate env were detected by 6 mo of age in two infants. In a fourth infant, HIV-1 IIIB env and early isolate env-specific CTLp were simultaneously detected at 12 mo of age. These results provide evidence that young infants can generate HIV-1-specific CTL responses and provide support for the concept of neonatal vaccination to prevent HIV-1 transmission. However, the early predominance of type-specific CTL detected in some young infants suggests that the use of vaccines based on laboratory strains of HIV-1 may not protect against vertical infection.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9104802&dopt=Abstract">Link to article in PubMed</a></p>
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2196268/
dc.subjectCloning, Molecular; Cross Reactions; Disease Progression; Disease Transmission, Vertical; Gene Products, env; Genes, env; HIV Infections; HIV-1; Hematopoietic Stem Cells; Humans; Infant; Infant, Newborn; Polymerase Chain Reaction; T-Lymphocytes, Cytotoxic; Time Factors
dc.subjectLife Sciences
dc.subjectMedicine and Health Sciences
dc.titleEarly HIV-1 envelope-specific cytotoxic T lymphocyte responses in vertically infected infants
dc.typeJournal Article
dc.source.journaltitleThe Journal of experimental medicine
dc.source.volume185
dc.source.issue7
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/gsbs_sp/988
dc.identifier.contextkey672516
html.description.abstract<p>High frequencies of cytotoxic T lymphocyte precursors (CTLp) recognizing HIV-1 laboratory strain gene products have been detected in adults within weeks of primary infection. In contrast, HIV-1-specific CTLp are uncommonly detected in infants younger than 6 mo. To address the hypothesis that the use of target cells expressing laboratory strain env gene products might limit the detection of HIV-1 env-specific CTLp in early infancy, recombinant vaccinia vectors (vv) expressing HIV-1 env genes from early isolates of four vertically infected infants were generated. The frequencies of CTLp recognizing target cells infected with vv-expressing env gene products from early isolates and HIV-1 IIIB were serially measured using limiting dilution followed by in vitro stimulation with mAb to CD3. In one infant, the detection of early isolate env-specific CTLp preceded the detection of IIIB-specific CTLp. CTLp recognizing HIV-1 IIIB and infant isolate env were detected by 6 mo of age in two infants. In a fourth infant, HIV-1 IIIB env and early isolate env-specific CTLp were simultaneously detected at 12 mo of age. These results provide evidence that young infants can generate HIV-1-specific CTL responses and provide support for the concept of neonatal vaccination to prevent HIV-1 transmission. However, the early predominance of type-specific CTL detected in some young infants suggests that the use of vaccines based on laboratory strains of HIV-1 may not protect against vertical infection.</p>
dc.identifier.submissionpathgsbs_sp/988
dc.contributor.departmentProgram in Molecular Medicine
dc.contributor.departmentDepartment of Pediatrics
dc.contributor.departmentGraduate School of Biomedical Sciences
dc.source.pages1153-61


This item appears in the following Collection(s)

Show simple item record